Solara Active Pharma Sciences Ltd.
Snapshot View

View in App

Prices View details >>

418.00 -19.15 ▼-4.4%

27 January 2023, 12:57:59 PM
Volume: 69,434

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.solara.co.in
Market Cap 1,525.88 Cr.
Enterprise Value(EV) 2,529.32 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -6.68 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 33.61 Trailing Twelve Months Ending 2022-12
Book Value / Share 416.12 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.02 Calculated using Price: 423.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 3.60 Cr. 35,996,267 Shares
FaceValue 10
Company Profile
Solara Active Pharma Sciences is a dynamic, entrepreneurial and customer-oriented API manufacturer. It has a legacy of over three decades and trace its origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. The company is a global, R&D focused, pureplay API company engaged in the manufacturing and development of APIs and offering Contract Manufacturing and Development Services for global companies.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.38%
1 Week
+0.48%
1 Month
-2.80%
3 Month
+1.10%
6 Month
+18.72%
1 Year
-56.17%
2 Year
-67.78%
5 Year
10 Year

Ratios View Details >>

5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 0.04 7.36 12.48 17.23 -3.75
Return on Capital Employed (%) 1.82 9.70 11.73 15.34 -0.67
Return on Assets (%) 0.02 3.14 5.57 9.34 -2.13

Balance Sheet View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 764 956 1,086 1,589 1,525 1,498
Non Curr. Liab. 315 344 333 206 299 212
Curr. Liab. 738 656 730 789 1,071 1,073
Minority Int. 4 4 4 4 2 2
Equity & Liab. 1,821 1,960 2,153 2,588 2,897 2,786
Non Curr. Assets 1,214 1,312 1,481 1,530 1,658 1,650
Curr. Assets 608 648 672 1,058 1,239 1,136
Misc. Exp. not W/O
Total Assets 1,821 1,960 2,153 2,588 2,897 2,786

Profit Loss View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 560 1,409 1,322 1,617 1,268 1,424
Other Income 2 12 28 29 20 24
Total Income 563 1,421 1,349 1,646 1,288 1,448
Total Expenditure -501 -1,197 -1,062 -1,231 -1,188 -1,325
PBIDT 62 224 287 415 100 123
Interest -25 -82 -78 -84 -75 -90
Depreciation -37 -84 -94 -109 -112 -113
Taxation 0 2 0 0 33 57
Exceptional Items -3 -1
PAT 0 59 115 221 -58 -24
Minority Interest 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 0 60 115 221 -58 -24
Adjusted EPS 0 23 43 62 -16 -7

Cash Flow View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 49 166 242 155 -242
Cash Fr. Inv. -85 -116 -359 -106 -243
Cash Fr. Finan. 68 -23 97 92 334
Net Change 31 27 -20 142 -151
Cash & Cash Eqvt 46 76 56 198 46

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 44.13 44.11 41.07 41.07 39.51 39.71 40.40 40.40 40.40
Public 55.87 55.89 58.93 58.93 60.49 60.29 59.60 59.60 59.60
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 17.09 16.42 8.86 13.55 29.44 27.51 27.98 28.18 33.73

Announcements View Details >>

Wed, 25 Jan 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Solara Active Pharma Sciences Limited has informed the Exchange about Link of Recording
Wed, 25 Jan 2023
Appointment
Solara Active Pharma Sciences Limited has informed the Exchange regarding Appointment of Mr Poorvank Purohit as Chief Executive Officer and as Key Managerial Personnel of the company w.e.f. February 03, 2023.
Wed, 25 Jan 2023
ESOP/ESOS/ESPS
SOLARA: Solara Active Pharma Sciences Limited has informed the Exchange regarding Grant of 94600 ESOP Options to the eligible employees.

Technical Scans View Details >>

Wed, 25 Jan 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,518.84 1,044.35 +0.4%
Divi's Laboratories Ltd. 88,552.35 3,368.85 +1.0%
Cipla Ltd. 83,862.25 1,048.25 +1.3%
Dr. Reddy's Laboratories Ltd. 69,879.98 4,330.00 +3.1%
Apollo Hospitals Enterprise Ltd. 60,777.77 4,221.10 -0.1%
Torrent Pharmaceuticals Ltd. 52,497.96 1,530.60 -1.7%
Abbott India Ltd. 45,101.64 21,200.00 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.79 1,044.35 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 29.71 3,368.85 +1.0%
Cipla Ltd. Consolidated 2022-09 32.68 1,048.25 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 22.47 4,330.00 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.39 4,221.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 65.87 1,530.60 -1.7%
Abbott India Ltd. Standalone 2022-09 51.15 21,200.00 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,044.35 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 7.33 3,368.85 +1.0%
Cipla Ltd. Consolidated 2022-09 3.83 1,048.25 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.36 4,330.00 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.15 4,221.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.62 1,530.60 -1.7%
Abbott India Ltd. Standalone 2022-09 16.62 21,200.00 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,044.35 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,368.85 +1.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,048.25 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,330.00 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,221.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,530.60 -1.7%
Abbott India Ltd. Standalone 2022-03 0.00 21,200.00 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,044.35 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,368.85 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,048.25 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,330.00 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,221.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,530.60 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 21,200.00 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,044.35 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,368.85 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,048.25 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,330.00 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,221.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,530.60 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 21,200.00 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,044.35 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,368.85 +1.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,048.25 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,330.00 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,221.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,530.60 -1.7%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,200.00 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,044.35 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,368.85 +1.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,048.25 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,330.00 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,221.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,530.60 -1.7%
Abbott India Ltd. Standalone 2022-03 798.70 21,200.00 -0.4%

FAQ's On Solara Active Pharma Sciences Ltd.

What is Solara Active Pharma share price?
Can I buy Solara Active Pharma shares now?
What is the Market Cap of Solara Active Pharma?
What are the key metrics to analyse Solara Active Pharma?
What is the 52 Week High and Low of Solara Active Pharma?
What is the trend of Solara Active Pharma share price?